ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

ONS The Largest And Still Growing With 13,000 Members

May 27, 1988

HHS To Award “Micro-Grants” For Public Health Programs.

July 20, 2001

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990